These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26096339)

  • 1. Educational attainment and motor burden in Parkinson's disease.
    Kotagal V; Bohnen NI; Müller ML; Koeppe RA; Frey KA; Langa KM; Albin RL
    Mov Disord; 2015 Jul; 30(8):1143-7. PubMed ID: 26096339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.
    Petrou M; Davatzikos C; Hsieh M; Foerster BR; Albin RL; Kotagal V; Müller ML; Koeppe RA; Herman WH; Frey KA; Bohnen NI
    Acad Radiol; 2016 May; 23(5):577-81. PubMed ID: 26874576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Educational attainment and motor burden in advanced Parkinson's disease - The emerging role of education in motor reserve.
    Blume J; Rothenfusser E; Schlaier J; Bogdahn U; Lange M
    J Neurol Sci; 2017 Oct; 381():141-143. PubMed ID: 28991666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural and dopaminergic correlates of fatigue in Parkinson's disease.
    Kang SY; Bang M; Hong JY; Oh J; Kim JS; Han YM; Chang SK; Lee SA; Yoon U; Shin NY
    J Neural Transm (Vienna); 2020 Mar; 127(3):301-309. PubMed ID: 31894419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.
    Bohnen NI; Müller ML; Zarzhevsky N; Koeppe RA; Bogan CW; Kilbourn MR; Frey KA; Albin RL
    Brain; 2011 Aug; 134(Pt 8):2358-65. PubMed ID: 21653540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal imaging evaluation of excessive daytime sleepiness in Parkinson's disease.
    Chondrogiorgi M; Tzarouchi LC; Zikou AK; Astrakas LG; Kosta P; Argyropoulou MI; Konitsiotis S
    Int J Neurosci; 2016; 126(5):422-8. PubMed ID: 26000811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible association between cerebral white matter atrophy and impaired performance of activities of daily living in patients with Parkinson's disease.
    Lu ZH; Chen YK; Fu XL; Chen QT; Yuan SL
    Folia Neuropathol; 2023; 61(3):266-272. PubMed ID: 37818687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does education modify motor compensation in Parkinson's disease?
    Sunwoo MK; Hong JY; Lee JJ; Lee PH; Sohn YH
    J Neurol Sci; 2016 Mar; 362():118-20. PubMed ID: 26944130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.
    Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural MRI in Idiopathic Parkinson's Disease.
    De Micco R; Russo A; Tessitore A
    Int Rev Neurobiol; 2018; 141():405-438. PubMed ID: 30314605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
    Bohnen NI; Kotagal V; Müller ML; Koeppe RA; Scott PJ; Albin RL; Frey KA; Petrou M
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1394-8. PubMed ID: 25454317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.
    Tsuruya K; Yoshida H; Haruyama N; Fujisaki K; Hirakata H; Kitazono T
    PLoS One; 2015; 10(12):e0143706. PubMed ID: 26632813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease.
    Ten Harmsen BL; van Rumund A; Aerts MB; Bergkamp MI; Esselink RAJ; Richard E; Meijer FJA; Bloem BR; van Wamelen DJ
    Parkinsonism Relat Disord; 2018 Apr; 49():28-33. PubMed ID: 29306636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural MRI substrates of cognitive impairment in neuromyelitis optica.
    Liu Y; Fu Y; Schoonheim MM; Zhang N; Fan M; Su L; Shen Y; Yan Y; Yang L; Wang Q; Zhang N; Yu C; Barkhof F; Shi FD
    Neurology; 2015 Oct; 85(17):1491-9. PubMed ID: 26423432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Apolipoprotein E4 Polymorphism on the Gray Matter Volume and the White Matter Integrity in Subjective Memory Impairment without White Matter Hyperintensities: Voxel-Based Morphometry and Tract-Based Spatial Statistics Study under 3-Tesla MRI.
    Lee YM; Ha JK; Park JM; Lee BD; Moon E; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
    J Neuroimaging; 2016; 26(1):144-9. PubMed ID: 25678236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease.
    Ham JH; Yun HJ; Sunwoo MK; Hong JY; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2015 Apr; 21(4):372-7. PubMed ID: 25697488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's Disease Risk Variant rs9638616 is Non-Specifically Associated with Altered Brain Structure and Function.
    Welton T; Teo TWJ; Chan LL; Tan EK; Tan LCS
    J Parkinsons Dis; 2024; 14(4):713-724. PubMed ID: 38640170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.